Archives

by in
Entry Author Date Location
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010 12/27/10 Boston
Aveo Gets Money from OSI, Merck Buys SmartCells, Glaxo Cancels Resveratrol Drug Trial, & More Boston-Area Life Sciences News 12/03/10 Boston
Glaxo Ends Resveratrol Drug Study 12/01/10 Boston
Biogen Strikes Deal with Knopp for ALS Drugs, Selecta Gets New CEO, Avantra Scores $7M, & More Boston-Area Life Sciences News 08/20/10 Boston
Former Sirtris Execs’ Nonprofit Starts Selling Resveratrol with Potential Anti-Aging Effects Online 08/12/10 Boston
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News 05/07/10 Boston
Glaxo Stops Study of Sirtris “Red Wine” Drug in Cancer Patients 05/05/10 Boston
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News 09/30/09 Boston
Sirtris’ Red Wine Chemical to Take Back Seat to “Potent” Diabetes Drugs 10/23/08 Boston
Sirtris’ Westphal Enjoying Life Under GSK Ownership; Hints at Positive Human Data on Next-Gen Drugs to Extend Healthy Life (and Still Partying on Fridays) 09/18/08 Boston
Barbara Walters to Feature Sirtris 03/31/08 Boston
Sirtris Returns to Its “Roots” in Crop Deal with Bayer 03/12/08 Boston
Sirtris Finds Anti-Cancer Effect, Teams with NIH 02/22/08 Boston
Sirtris Anti-Aging Drug Generates Buzz, But May Already Be Old News 01/08/08 Boston
Page 1 of 1